Eisai Past Earnings Performance

Past criteria checks 1/6

Eisai's earnings have been declining at an average annual rate of -18.4%, while the Pharmaceuticals industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 3.4% per year. Eisai's return on equity is 4.9%, and it has net margins of 5.7%.

Key information

-18.4%

Earnings growth rate

-18.4%

EPS growth rate

Pharmaceuticals Industry Growth3.4%
Revenue growth rate3.4%
Return on equity4.9%
Net Margin5.7%
Next Earnings Update02 Aug 2024

Recent past performance updates

Recent updates

Is Eisai (TSE:4523) A Risky Investment?

Jul 11
Is Eisai (TSE:4523) A Risky Investment?

Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Jul 11
Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Eisai Co., Ltd.'s (TSE:4523) P/E Is On The Mark

Jun 10
Eisai Co., Ltd.'s (TSE:4523) P/E Is On The Mark

Here's Why Eisai (TSE:4523) Can Manage Its Debt Responsibly

Apr 11
Here's Why Eisai (TSE:4523) Can Manage Its Debt Responsibly

Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Mar 18
Eisai (TSE:4523) Has Affirmed Its Dividend Of ¥80.00

Eisai's (TSE:4523) Dividend Will Be ¥80.00

Mar 04
Eisai's (TSE:4523) Dividend Will Be ¥80.00

Revenue & Expenses Breakdown

How Eisai makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:4523 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24741,75142,406364,084169,021
31 Dec 23749,46045,421346,208176,070
30 Sep 23759,32948,096346,619174,257
30 Jun 23757,07548,874341,916175,647
31 Mar 23744,40255,432348,139172,999
31 Dec 22737,09826,705373,875169,848
30 Sep 22752,50032,233382,752173,324
30 Jun 22741,59432,690374,428168,422
31 Mar 22756,22647,954356,847171,738
31 Dec 21712,93557,311317,150165,418
30 Sep 21691,25062,508293,153162,699
30 Jun 21679,25359,855282,369161,584
31 Mar 21645,94242,119272,568150,299
31 Dec 20707,88893,682271,476145,248
30 Sep 20713,400120,571261,973139,628
30 Jun 20707,203124,523253,516141,217
31 Mar 20695,621121,767248,554140,116
31 Dec 19661,64696,659244,091146,367
30 Sep 19631,97457,725239,503147,863
30 Jun 19643,53172,747233,180140,143
31 Mar 19642,83463,386223,798144,844
31 Dec 18627,36763,714212,469139,100
30 Sep 18625,10665,679195,229138,461
30 Jun 18611,49954,347186,198140,514
31 Mar 18600,05451,845179,915139,579
31 Dec 17569,81429,048178,312134,955
30 Sep 17554,27630,269178,090123,639
30 Jun 17544,02729,425176,249119,503
31 Mar 17539,09739,358175,633112,478
31 Dec 16530,69655,031175,240110,471
30 Sep 16542,31371,812178,825114,420
30 Jun 16545,60269,227182,036115,750
31 Mar 16547,92254,933188,227122,307
31 Dec 15566,43544,886192,375125,396
30 Sep 15554,91243,871191,627132,652
30 Jun 15554,88543,021192,617135,534
31 Mar 15548,46543,254189,910131,907
31 Dec 14560,79540,15290,324228,412
30 Sep 14561,93815,717126,410192,643
30 Jun 14578,94529,225163,903159,644
31 Mar 14600,36332,955210,544130,544
31 Dec 13590,15243,756223,092120,377
30 Sep 13592,67951,447221,391120,377

Quality Earnings: 4523 has high quality earnings.

Growing Profit Margin: 4523's current net profit margins (5.7%) are lower than last year (7.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4523's earnings have declined by 18.4% per year over the past 5 years.

Accelerating Growth: 4523's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4523 had negative earnings growth (-23.5%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (12.7%).


Return on Equity

High ROE: 4523's Return on Equity (4.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.